Hospital
Southern California Healthcare System, INC
Southern California Healthcare System, INC was paid $8.32M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 0450, Emergency room services — 16% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA HEALTHCARE SYSTEM, INC
HOLLYWOOD, CA 90028
HOLLYWOOD, CA 90028
33aNPI1023010113assigned 06/02/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.32M
24GClaims426,150
24DCodes billed182
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#199 of 410
Median peer was paid$6.90M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 69,545 | $974K | |
| 2019 | 65,260 | $1.09M | |
| 2020 | 51,216 | $886K | |
| 2021 | 57,100 | $1.32M | |
| 2022 | 62,190 | $1.97M | |
| 2023 | 66,136 | $1.29M | |
| 2024incomplete | 54,703 | $794K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 16% | 31,131 | 28,002 | $1.34M |
| 0206 | 5.8% | 210 | 199 | $479K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5.5% | 3,059 | 3,008 | $461K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.4% | 12,158 | 10,742 | $447K |
| 0121 | 4.8% | 128 | 122 | $397K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.6% | 8,195 | 7,682 | $387K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.1% | 3,958 | 3,825 | $341K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.9% | 10,132 | 9,224 | $328K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.8% | 3,724 | 3,589 | $317K |
| 0360 | 2.8% | 2,517 | 1,876 | $231K | |
| 0120 | 2.6% | 81 | 74 | $217K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 11,352 | 10,609 | $197K |
170 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.0% | 3,286 | $170K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 4,574 | $145K |
| 80053 | Comprehensive metabolic panel | 1.7% | 17,539 | $142K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 25,509 | $133K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1.3% | 889 | $109K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 10,226 | $107K |
| J2785 | Injection, regadenoson, 0.1 mg | 1.3% | 853 | $105K |
| 0516 | 1.2% | 4,925 | $101K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 4,765 | $98K |
| 0750 | 1.1% | 673 | $94K | |
| J3490 | Unclassified drugs | 1.0% | 11,314 | $87K |
| 0710 | 1.0% | 3,668 | $86K | |
| 78454 | <1% | 662 | $83K | |
| 93017 | <1% | 1,876 | $74K | |
| 99199 | Unlisted special service, procedure or report | <1% | 1,973 | $74K |
| 0250 | <1% | 12,311 | $73K | |
| 0760 | <1% | 2,166 | $72K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,902 | $72K |
| 99221 | <1% | 2,136 | $67K | |
| 83880 | <1% | 3,329 | $66K | |
| 84484 | <1% | 9,435 | $65K | |
| Z7502 | <1% | 1,698 | $64K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,561 | $49K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,921 | $45K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 453 | $45K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,616 | $44K |
| 99283 | Emergency room visit (moderate) | <1% | 757 | $43K |
| 83690 | <1% | 6,992 | $34K | |
| 78466 | <1% | 448 | $33K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,171 | $31K |
| 82550 | <1% | 6,788 | $29K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,621 | $28K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,321 | $28K |
| 85730 | <1% | 6,158 | $27K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 841 | $24K |
| 87040 | <1% | 2,203 | $19K | |
| 99284 | Emergency room visit (serious) | <1% | 265 | $19K |
| 90715 | <1% | 598 | $18K | |
| 85610 | <1% | 6,547 | $18K | |
| 81003 | <1% | 12,870 | $18K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 93 | $18K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 351 | $16K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 447 | $16K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,157 | $16K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,453 | $15K |
| 93880 | <1% | 126 | $15K | |
| 84703 | <1% | 3,037 | $15K | |
| 80076 | <1% | 1,901 | $14K | |
| 0761 | <1% | 670 | $14K | |
| 83605 | <1% | 2,009 | $13K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 820 | $13K |
| 93970 | <1% | 83 | $12K | |
| 0270 | <1% | 3,774 | $12K | |
| 81001 | <1% | 6,180 | $11K | |
| 86328 | <1% | 365 | $11K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 236 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,916 | $11K |
| 81025 | <1% | 2,379 | $11K | |
| 0370 | <1% | 226 | $10K | |
| 82553 | <1% | 1,224 | $10K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,576 | $10K |
| 87088 | <1% | 2,086 | $9K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 638 | $9K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,706 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,323 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 518 | $8K |
| 83735 | <1% | 1,594 | $8K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,474 | $8K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 550 | $8K |
| 94644 | <1% | 541 | $7K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 901 | $7K |
| 73030 | <1% | 406 | $7K | |
| 73610 | <1% | 384 | $7K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 46 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,263 | $7K |
| 99285 | Emergency room visit (most serious) | <1% | 40 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 467 | $7K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,429 | $6K |
| 99406 | <1% | 606 | $6K | |
| 82948 | <1% | 1,470 | $6K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 909 | $6K |
| 70486 | <1% | 67 | $5K | |
| 73630 | <1% | 276 | $5K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 933 | $5K |
| Z7500 | <1% | 140 | $5K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 856 | $4K |
| 93225 | <1% | 168 | $4K | |
| 82150 | <1% | 1,092 | $4K | |
| 80061 | Lipid panel | <1% | 466 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 388 | $4K |
| 93924 | <1% | 41 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 75 | $3K |
| 93226 | <1% | 77 | $3K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 24 | $3K |
| 87186 | <1% | 585 | $3K | |
| 72131 | <1% | 40 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,242 | $3K |
| 87077 | <1% | 591 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 342 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 520 | $2K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 14 | $2K |
| 73130 | <1% | 116 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 39 | $2K |
| 0258 | <1% | 281 | $2K | |
| 73560 | <1% | 162 | $2K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 27 | $2K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 104 | $2K |
| 74247 | <1% | 44 | $2K | |
| 72100 | <1% | 83 | $2K | |
| 82140 | <1% | 239 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 53 | $1K |
| 0320 | <1% | 549 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 31 | $1K |
| 0300 | <1% | 910 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 168 | $1K |
| 0762 | <1% | 22 | $1K | |
| 94645 | <1% | 66 | $1K | |
| A4649 | Surgical supply; miscellaneous | <1% | 1,862 | $1K |
| 85379 | <1% | 135 | $1K | |
| 87420 | <1% | 150 | $798.04 | |
| 84702 | <1% | 70 | $784.07 | |
| 73590 | <1% | 53 | $778.63 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 52,547 | $757.44 |
| 73110 | <1% | 32 | $633.63 | |
| 86901 | <1% | 245 | $615.93 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,143 | $588.06 |
| 87081 | <1% | 130 | $576.11 | |
| Z7610 | <1% | 38 | $527.53 | |
| 80164 | <1% | 89 | $498.42 | |
| 86900 | <1% | 232 | $493.87 | |
| A9150 | Non-prescription drugs | <1% | 226 | $449.61 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 191 | $405.10 |
| 73562 | <1% | 15 | $378.96 | |
| 88304 | <1% | 45 | $375.64 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | <1% | 13 | $346.45 |
| 0636 | <1% | 737 | $335.23 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 19 | $248.28 |
| 84100 | <1% | 82 | $242.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 45 | $208.49 |
| 0306 | <1% | 640 | $203.18 | |
| 73502 | <1% | 12 | $189.74 | |
| 86850 | <1% | 43 | $184.71 | |
| 74018 | <1% | 14 | $142.48 | |
| 94760 | <1% | 27 | $138.25 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 13 | $126.97 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 17 | $91.06 |
| 86140 | <1% | 42 | $85.32 | |
| 87070 | <1% | 12 | $66.98 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 13 | $66.68 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 14 | $52.19 |
| 84439 | <1% | 14 | $48.17 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 14 | $45.40 |
| 88300 | <1% | 15 | $41.65 | |
| 84550 | <1% | 12 | $32.25 | |
| 85651 | <1% | 12 | $16.89 | |
| 0730 | 0% | 432 | $0.00 | |
| 0424 | 0% | 163 | $0.00 | |
| 0430 | 0% | 97 | $0.00 | |
| 0483 | 0% | 177 | $0.00 | |
| A0425 | Ground mileage, per statute mile | 0% | 172 | $0.00 |
| 0402 | 0% | 106 | $0.00 | |
| 0302 | 0% | 39 | $0.00 | |
| 0305 | 0% | 97 | $0.00 | |
| 0307 | 0% | 368 | $0.00 | |
| 0420 | 0% | 265 | $0.00 | |
| 0324 | 0% | 30 | $0.00 | |
| 0350 | 0% | 71 | $0.00 | |
| 0301 | 0% | 305 | $0.00 | |
| 0259 | 0% | 15 | $0.00 | |
| 0434 | 0% | 110 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZILKOW, JON (CHIEF FINANCIAL OFFICER)
Parent organizationALTA HOSPITALS SYSTEM, LLC